{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:20:44Z","timestamp":1783405244222,"version":"3.54.6"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The underlying mechanisms linking structural and metabolic alterations of idiopathic Parkinson\u2019s disease (IPD) remain poorly understood. Utilizing integrated PET\/MR for its precise spatial correlation, this study investigated the temporal relationship between gray matter (GM) atrophy and reduced FDG SUVR (RFS) across IPD stages to provide insights for early diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective study recruited 90 IPD patients stratified by Hoehn-Yahr (H-Y) stage into mild, moderate, and severe groups, alongside 30 age-matched healthy controls (HC). All participants underwent integrated\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/MR imaging. SPM was used to extract the GM volume (VGM) and standardized uptake value ratio for each brain region. Group differences were analyzed with one-way ANOVA and Bonferroni tests. Spearman correlation analysis was utilized to evaluate the associations of both VGM and metabolic changes with H-Y staging. Individual\n                      <jats:italic>Z<\/jats:italic>\n                      -scores for VGM and metabolic alterations were calculated, and their relationship was examined using Spearman\/Pearson correlation, followed by paired t-tests to compare their differences.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      With disease progression, GM atrophy and RFS in IPD patients gradually extend from focal to widespread patterns. A characteristic pattern of cerebral hypermetabolism was observed in IPD. H-Y stage demonstrated a significant inverse correlation with the extent of both brain GM atrophy (affecting 82 out of 90 regions) and RFS (affecting 20 regions). Conversely, it was positively correlated with hypermetabolism in regions including the sensorimotor cortex, amygdala, and globus pallidus. Moderate correlations between atrophy and RFS were confined to the left inferior parietal lobule (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f0.619,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001) and superior temporal gyrus of the temporal pole (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f0.612,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001) only in severe group. In early stages, the number of regions where RFS predominated over atrophy (57 regions) substantially exceeded those where atrophy was more severe (1 region). In late stages, the number of regions with more pronounced atrophy than RFS (25 regions) surpassed that of regions where RFS was dominant (12 regions).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Widespread RFS predominates during early stages, whereas structural atrophy gradually becomes the dominant imaging feature as the disease advances. These alterations are significantly correlated with disease severity, underscoring the potential of multimodal imaging biomarkers for the early diagnosis of IPD and monitor its progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1757469","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:46:10Z","timestamp":1783403170000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated PET\/MRI for the evaluation of gray matter atrophy and metabolic changes in idiopathic Parkinson\u2019s disease"],"prefix":"10.3389","volume":"18","author":[{"given":"Yanxia","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]},{"name":"Key Laboratory of Molecular Imaging Medicine of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]},{"name":"Key Laboratory of Molecular Imaging Medicine of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]},{"name":"Key Laboratory of Molecular Imaging Medicine of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]},{"name":"Key Laboratory of Molecular Imaging Medicine of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]},{"name":"Key Laboratory of Molecular Imaging Medicine of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]},{"name":"Key Laboratory of Molecular Imaging Medicine of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingliang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Magnetic Resonance Imaging, First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"101594","DOI":"10.1016\/j.nicl.2018.11.004","article-title":"FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: a whole-brain multimodal imaging meta-analysis","volume":"21","author":"Albrecht","year":"2019","journal-title":"Neuroimage Clin."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3389\/fneur.2019.01217","article-title":"Blood flow and glucose metabolism dissociation in the putamen is predictive of levodopa induced dyskinesia in Parkinson's disease patients","volume":"10","author":"Aljuaid","year":"2019","journal-title":"Front. Neurol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/mds.29375","article-title":"Synaptic density and glucose consumption in patients with lewy body diseases: an [(11) C]UCB-J and [(18) F]FDG PET study","volume":"38","author":"Andersen","year":"2023","journal-title":"Mov. Disord."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/life15081169","article-title":"The search for disease modification in Parkinson's disease-a review of the literature","volume":"15","author":"Barber","year":"2025","journal-title":"Life"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.expneurol.2017.10.002","article-title":"Compensatory mechanisms in Parkinson's disease: circuits adaptations and role in disease modification","volume":"298","author":"Blesa","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2967\/jnumed.111.089946","article-title":"Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study","volume":"52","author":"Bohnen","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/mds.26592","article-title":"Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease","volume":"31","author":"Breen","year":"2016","journal-title":"Mov. Disord."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neurobiolaging.2021.08.020","article-title":"Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease","volume":"109","author":"Charisse","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fneur.2020.00080","article-title":"Imaging biomarkers for neurodegeneration in Presymptomatic familial frontotemporal lobar degeneration","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Neurol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"104121","DOI":"10.1016\/j.lpm.2022.104121","article-title":"Functional imaging for neurodegenerative diseases","volume":"51","author":"Chollet","year":"2022","journal-title":"Presse Med."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e1505","DOI":"10.6061\/clinics\/2020\/e1505","article-title":"Gray matter atrophy in Parkinson's disease and the parkinsonian variant of multiple system atrophy: a combined ROI- and voxel-based morphometric study","volume":"75","author":"Cui","year":"2020","journal-title":"Clinics (Sao Paulo)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"342ra78","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"\u03b1-synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41531-024-00786-z","article-title":"The value of PET\/CT in the diagnosis and differential diagnosis of Parkinson's disease: a dual-tracer study","volume":"10","author":"Du","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1212\/wnl.57.11.2083","article-title":"Metabolic correlates of levodopa response in Parkinson's disease","volume":"57","author":"Feigin","year":"2001","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"giae049","DOI":"10.1093\/gigascience\/giae049","article-title":"CAT: a computational anatomy toolbox for the analysis of structural MRI data","volume":"13","author":"Gaser","year":"2024","journal-title":"Gigascience"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"626128","DOI":"10.3389\/fncel.2021.626128","article-title":"Molecular mechanisms underlying synaptic and axon degeneration in Parkinson's disease","volume":"15","author":"Gcwensa","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fneur.2018.00295","article-title":"Alpha-synuclein: from early synaptic dysfunction to neurodegeneration","volume":"9","author":"Ghiglieri","year":"2018","journal-title":"Front. Neurol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1093\/brain\/awu159","article-title":"Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process","volume":"137","author":"Gonzalez-Redondo","year":"2014","journal-title":"Brain"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","article-title":"Disruption of mitochondrial complex I induces progressive parkinsonism","volume":"599","author":"Gonzalez-Rodriguez","year":"2021","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fneur.2016.00243","article-title":"Pattern of reduced functional connectivity and structural abnormalities in Parkinson's disease: an exploratory study","volume":"7","author":"Guimaraes","year":"2016","journal-title":"Front. Neurol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/RCT.0000000000001763","article-title":"The diagnostic value of 18F-FDG PET in Parkinson disease based on voxel analysis","volume":"49","author":"Han","year":"2025","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"20029","DOI":"10.1038\/s41598-025-02672-x","article-title":"The combination of the (18)F-FDG PET and susceptibility-weighted imaging for diagnosis of cerebral glucose metabolism and iron deposition in Parkinson's disease","volume":"15","author":"He","year":"2025","journal-title":"Sci. Rep."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/mdc3.13687","article-title":"Striatal dopamine loss in early Parkinson's disease: systematic review and novel analysis of dopamine transporter imaging","volume":"10","author":"Heng","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/brain\/awm086","article-title":"Changes in network activity with the progression of Parkinson's disease","volume":"130","author":"Huang","year":"2007","journal-title":"Brain"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1073\/pnas.1214912110","article-title":"Cortical energy demands of signaling and nonsignaling components in brain are conserved across mammalian species and activity levels","volume":"110","author":"Hyder","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/mds.25240","article-title":"Progression of cortical thinning in early Parkinson's disease","volume":"27","author":"Ibarretxe-Bilbao","year":"2012","journal-title":"Mov. Disord."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3174\/ajnr.A4447","article-title":"Longitudinal study of gray matter changes in Parkinson disease","volume":"36","author":"Jia","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e001215","DOI":"10.1136\/bmjno-2025-001215","article-title":"Understanding the progression of Parkinson's disease: a review","volume":"7","author":"Kempster","year":"2025","journal-title":"BMJ Neurol. Open."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1002\/mds.28706","article-title":"International multicenter analysis of brain structure across clinical stages of Parkinson's disease","volume":"36","author":"Laansma","year":"2021","journal-title":"Mov. Disord."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/geriatrics6040110","article-title":"Cognitive and behavior deficits in Parkinson's disease with alteration of FDG-PET irrespective of age","volume":"6","author":"Lauretani","year":"2021","journal-title":"Geriatrics"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00415-015-7929-7","article-title":"The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions","volume":"263","author":"Lewis","year":"2016","journal-title":"J. Neurol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/MNM.0000000000001951","article-title":"Network topology and metabolic alterations in early- and mid-stage Parkinson's disease: insights from fluorodeoxyglucose PET imaging","volume":"46","author":"Li","year":"2025","journal-title":"Nucl. Med. Commun."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.21037\/qims-24-2047","article-title":"Correlation of Parkinson's disease severity and (18)F-FDG and (18)F-FP-DTBZ PET","volume":"15","author":"Li","year":"2025","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"102386","DOI":"10.1016\/j.nicl.2020.102386","article-title":"Image reconstruction methods affect software-aided assessment of pathologies of [(18)F]flutemetamol and [(18)F]FDG brain-PET examinations in patients with neurodegenerative diseases","volume":"28","author":"Lindstrom","year":"2020","journal-title":"Neuroimage Clin."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fnagi.2020.00125","article-title":"Brain functional and structural signatures in Parkinson's disease","volume":"12","author":"Liu","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","article-title":"A cellular perspective on brain energy metabolism and functional imaging","volume":"86","author":"Magistretti","year":"2015","journal-title":"Neuron"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nicl.2018.08.006","article-title":"FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease","volume":"20","author":"Matthews","year":"2018","journal-title":"Neuroimage Clin."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00259-019-04570-7","article-title":"Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts","volume":"47","author":"Meles","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/23279095.2024.2443591","article-title":"Cortical and subcortical gray matter volume and cognitive impairment in Parkinson's disease","author":"Moradi","year":"2024","journal-title":"Appl. Neuropsychol. Adult"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1093\/brain\/awr233","article-title":"Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease","volume":"134","author":"Nandhagopal","year":"2011","journal-title":"Brain"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/jnc.15561","article-title":"Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool","volume":"164","author":"Nicastro","year":"2023","journal-title":"J. Neurochem."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3390\/brainsci13081173","article-title":"Visual dysfunction in Parkinson's disease","volume":"13","author":"Nieto-Escamez","year":"2023","journal-title":"Brain Sci."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1073\/pnas.0501703102","article-title":"The contribution of GABA to glutamate\/glutamine cycling and energy metabolism in the rat cortex in vivo","volume":"102","author":"Patel","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1038\/s41598-017-06724-9","article-title":"Early synaptic dysfunction induced by \u03b1-synuclein in a rat model of Parkinson's disease","volume":"7","author":"Phan","year":"2017","journal-title":"Sci. Rep."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3174\/ajnr.A7613","article-title":"Multimodality imaging in primary progressive aphasia","volume":"43","author":"Roytman","year":"2022","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cortex.2024.07.004","article-title":"Cerebral glucose metabolism in Alzheimer's disease","volume":"179","author":"Salmon","year":"2024","journal-title":"Cortex"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.parkreldis.2019.09.031","article-title":"Longitudinal intracortical diffusivity changes in de-novo Parkinson's disease: a promising imaging biomarker","volume":"68","author":"Sampedro","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1007\/s00415-020-09863-8","article-title":"Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature","volume":"268","author":"Sarasso","year":"2021","journal-title":"J. Neurol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/diagnostics13010006","article-title":"Differences in striatal metabolism in [(18)F]FDG PET in Parkinson's disease and atypical parkinsonism","volume":"13","author":"Seiffert","year":"2022","journal-title":"Diagnostics"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"880","DOI":"10.4103\/aian.aian_642_21","article-title":"(18)F-FDG PET\/CT and 99mTc-TRODAT scan findings in the variants of progressive supranuclear palsy and correlation with clinical findings","volume":"25","author":"Seniaray","year":"2022","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1007\/s00259-025-07070-z","article-title":"Imaging biomarkers of cortical neurodegeneration underlying cognitive impairment in Parkinson's disease","volume":"52","author":"Silva-Rodriguez","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.3390\/s25134230","article-title":"Data-driven image-based protocol for brain PET image harmonization","volume":"25","author":"Stokelj","year":"2025","journal-title":"Sensors"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/cells15050451","article-title":"Alpha-synuclein in neurodegeneration: from shared biology to disease-specific phenotypes","volume":"15","author":"Su","year":"2026","journal-title":"Cells"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"105229","DOI":"10.1016\/j.nbd.2020.105229","article-title":"PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats","volume":"149","author":"Thomsen","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.22038\/aojnmb.2017.26684.1186","article-title":"Characteristics of smoothing filters to achieve the guideline recommended positron emission tomography image without harmonization","volume":"6","author":"Tsutsui","year":"2018","journal-title":"Asia Ocean J. Nucl. Med. Biol."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1007\/s00259-024-06993-3","article-title":"Presynaptic terminal integrity is associated with glucose metabolism in Parkinson's disease","volume":"52","author":"Wang","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/brain\/aww175","article-title":"Visual dysfunction in Parkinson's disease","volume":"139","author":"Weil","year":"2016","journal-title":"Brain"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/1673-5374.391180","article-title":"Recent progress in the applications of presynaptic dopaminergic positron emission tomography imaging in parkinsonism","volume":"20","author":"Yang","year":"2025","journal-title":"Neural Regen. Res."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"e1514","DOI":"10.1002\/hsr2.1514","article-title":"Comparing the hippocampal volumetric atrophy between demented and nondemented individuals with Parkinson's disease: a systematic review and meta-analysis","volume":"6","author":"Yazdan Panah","year":"2023","journal-title":"Health Sci. Rep."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1002\/hbm.26443","article-title":"Association between gene expression and functional-metabolic architecture in Parkinson's disease","volume":"44","author":"Zang","year":"2023","journal-title":"Hum. Brain Mapp."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1016\/j.acra.2024.08.016","article-title":"Accuracy of (18)F-FDG PET imaging in differentiating Parkinson's disease from atypical parkinsonian syndromes: a systematic review and meta-analysis","volume":"31","author":"Zhao","year":"2024","journal-title":"Acad. Radiol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1757469\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:46:11Z","timestamp":1783403171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1757469\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":65,"alternative-id":["10.3389\/fnagi.2026.1757469"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1757469","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"article-number":"1757469"}}